Medtronic Vascular
Clinical trials sponsored by Medtronic Vascular, explained in plain language.
A division of Medtronic specializing in vascular medical devices.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New balloon treatment for heart disease under study Results expected Feb 2027 (estimated)
- Tiny nerve zap could reveal secrets of blood pressure control Results expected Feb 2027 (estimated)
- 5,000-Patient registry tests kidney nerve procedure for Tough-to-Treat high blood pressure Results expected Jun 2027 (estimated)
- New shortcut for blood pressure treatment? Results expected Jun 2027 (estimated)
-
Could zapping kidney nerves tame tough high blood pressure?
Disease control OngoingThis study tests a device that uses radiofrequency energy to calm overactive kidney nerves, which can drive high blood pressure. About 1,900 adults with uncontrolled hypertension will receive the procedure and be followed for years. The goal is to see if this approach safely and …
Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New stent shows promise in unclogging heart arteries
Disease control OngoingThis study tests a newer drug-coated stent (Resolute Onyx) against an older one (Resolute Integrity) in 550 people with blocked heart arteries in China. The goal is to see if the new stent works better at keeping arteries open after angioplasty. Participants receive one of the tw…
Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New stent aims to keep heart arteries open longer
Disease control OngoingThis study tests a special stent coated with a drug called zotarolimus to treat people with blocked heart arteries. The stent is placed during a procedure to open the artery and slowly releases medication to prevent re-blockage. About 591 participants in China are being followed …
Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC